Biocardia announces participation at the a.g.p. biotech & specialty pharma conference october 13, 2021 (virtual conference)

San carlos, calif., oct. 06, 2021 (globe newswire) -- biocardia®, inc. (nasdaq: bcda), a company focused on developing cellular and cell derived therapeutics for the treatment of cardiovascular diseases, today announced it will be participating in the a.g.p biotech & specialty pharma conference taking place virtually on october 13, 2021.
BCDA Ratings Summary
BCDA Quant Ranking